Cargando…

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax

Vaccination is the most effective prophylactic tool against infectious diseases. Despite continued efforts to control malaria, the disease still generally represents a significant unmet medical need. Microcrystalline tyrosine (MCT) is a well described depot used in licensed allergy immunotherapy pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabral-Miranda, Gustavo, Heath, Matthew D., Mohsen, Mona O., Gomes, Ariane C., Engeroff, Paul, Flaxman, Amy, Leoratti, Fabiana M. S., El-Turabi, Aadil, Reyes-Sandoval, Arturo, Skinner, Murray A., Kramer, Matthias F., Bachmann, Martin F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492007/ https://www.ncbi.nlm.nih.gov/pubmed/28468322 http://dx.doi.org/10.3390/vaccines5020010

Ejemplares similares

Microcrystalline Tyrosine (MCT(®)): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2017)

Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT(®))
por: Heath, Matthew D., et al.
Publicado: (2020)

Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine
por: Alves, Eduardo, et al.
Publicado: (2017)

Quantitative characterization of hemozoin in Plasmodium berghei and vivax
por: Pisciotta, John M., et al.
Publicado: (2017)

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2018)

Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design
por: C. Gomes, Ariane, et al.
Publicado: (2019)

Early Transcriptional Signature in Dendritic Cells and the Induction of Protective T Cell Responses Upon Immunization With VLPs Containing TLR Ligands—A Role for CCL2
por: Gomes, Ariane C., et al.
Publicado: (2019)

Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines
por: Gomes, Ariane C., et al.
Publicado: (2017)

Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer
por: Mohsen, Mona O., et al.
Publicado: (2019)

The Immunogenicity of a VLP-based Malaria Vaccine Targeting CSP in Pregnant and Neonatal Mice
por: Jelínková, Lucie, et al.
Publicado: (2023)

The Prospects of an Active Vaccine Against Asthma Targeting IL-5
por: Bachmann, Martin F., et al.
Publicado: (2018)

A meta‐analysis on allergen‐specific immunotherapy using MCT(®) (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis
por: Becker, Sven, et al.
Publicado: (2021)

Plasmodium vivax malaria vaccines: Why are we where we are?
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2013)

Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
por: Klimek, Ludger, et al.
Publicado: (2018)

Biodegradation Study of Microcrystalline Chitosan and Microcrystalline Chitosan/β-TCP Complex Composites
por: Pighinelli, Luciano, et al.
Publicado: (2012)

Neutrophil Paralysis in Plasmodium vivax Malaria
por: Leoratti, Fabiana Maria de Souza, et al.
Publicado: (2012)

Transmission-blocking compound candidates against Plasmodium vivax using P. berghei as an initial screening
por: Fabbri, Camila, et al.
Publicado: (2021)

Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy
por: Zeltins, Andris, et al.
Publicado: (2017)

Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza
por: Heath, M. D, et al.
Publicado: (2017)

MicroCrystalline Tyrosine-adsorbed immunotherapy
por: Al Saleh, Helal, et al.
Publicado: (2022)

Interaction between Borrelia miyamotoi variable major proteins Vlp15/16 and Vlp18 with plasminogen and complement
por: Schmidt, Frederik L., et al.
Publicado: (2021)

Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein
por: Benen, Thomas D, et al.
Publicado: (2014)

RNA and Toll-Like Receptor 7 License the Generation of Superior Secondary Plasma Cells at Multiple Levels in a B Cell Intrinsic Fashion
por: Krueger, Caroline C., et al.
Publicado: (2019)

Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
por: Porst, Theresa, et al.
Publicado: (2021)

Inhibition of Hypothalamic MCT4 and MCT1–MCT4 Expressions Affects Food Intake and Alters Orexigenic and Anorexigenic Neuropeptide Expressions
por: Elizondo-Vega, Roberto, et al.
Publicado: (2019)

A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development
por: Atcheson, Erwan, et al.
Publicado: (2021)

On the Effect of Thermodynamic Equilibrium on the Assembly Efficiency of Complex Multi-Layered Virus-Like Particles (VLP): the Case of Rotavirus VLP
por: Roldão, António, et al.
Publicado: (2012)

VLP‐factory™ and ADDomer(©): Self‐assembling Virus‐Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display
por: Sari‐Ak, Duygu, et al.
Publicado: (2021)

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
por: Doucet, Marika, et al.
Publicado: (2017)

A genetically modified Plasmodium berghei parasite as a surrogate for whole-sporozoite vaccination against P. vivax malaria
por: Moita, Diana, et al.
Publicado: (2022)

Immunogenicity of adjuvanted plant-produced SARS-CoV-2 Beta spike VLP vaccine in New Zealand white rabbits
por: O'Kennedy, Martha M, et al.
Publicado: (2023)

VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
por: Prates-Syed, Wasim A., et al.
Publicado: (2021)

RNA Phage VLP-Based Vaccine Platforms
por: Peabody, David S., et al.
Publicado: (2021)

Erythro-VLP: Erythrocyte Virus-Like-Particles
por: Himbert, Sebastian, et al.
Publicado: (2021)

Rapid Structure Determination of Microcrystalline Molecular Compounds Using Electron Diffraction
por: Gruene, Tim, et al.
Publicado: (2018)

Virus-like particle (VLP)-based vaccines for pandemic influenza: Performance of a VLP vaccine during the 2009 influenza pandemic
por: López-Macías, Constantino
Publicado: (2012)

Influence of Water on the Structure and Dielectric Properties of the Microcrystalline and Nano-Cellulose
por: Kovalov, Kostiantyn M., et al.
Publicado: (2017)

Antigenicity and Immunogenicity of Plasmodium vivax Merozoite Surface Protein-3
por: Bitencourt, Amanda R., et al.
Publicado: (2013)

Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells
por: Kershaw, Stephen, et al.
Publicado: (2015)

Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis
por: Sheng, Gaohong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vlmh100uqju6ac64ngskqboe50